Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Allarity Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 3 | 10 | +7 |
| Shares | 26.0K | 339.8K | +313.8K (+1,205.3%) |
| Value | $270.0K | $694.0K | +$424.0K (+157.0%) |
New holders (9)
Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 114,227 | $233.0K | 0.00% |
| Millennium Management LLC | 94,082 | $192.0K | 0.00% |
| LMR Partners LLP | 51,378 | $105.0K | 0.00% |
| Morgan Stanley | 31,912 | $65.0K | 0.00% |
| Bridgeway Capital Management, LLC | 20,000 | $41.0K | 0.00% |
| Geode Capital Management, LLC | 12,315 | $25.0K | 0.00% |
| Citigroup Inc | 10,076 | $21.0K | 0.00% |
| Bank of America Corp | 1,306 | $3.00K | 0.00% |
| Wells Fargo & Company | 47 | $0 | 0.00% |
Sold out (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| ExodusPoint Capital Management, LP | 25,917 | $269.0K |
| Tower Research Capital LLC (TRC) | 9 | $0 |